Citation Impact
2 from Science/Nature 60 standout
Citing Papers
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
Works of Michael Binks being referenced
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF‐06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects
2017
Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.
2012
Author Peers
| Author | Molecular Biology | Rheumatology | Oncology | Immunology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Michael Binks | 238 | 384 | 166 | 237 | 29 | 906 | |
| R. R. Recker | 360 | 41 | 455 | 11 | 21 | 942 | |
| Anastasia Gorbunova | 14 | 1 | 1 | 7 | 367 | ||
| Aniruddh Shrivastava | 2 | 7 | 366 | ||||
| Joe Buckley | 44 | 5 | 6 | 340 | |||
| ESG Sergeant | 68 | 6 | 13 | 348 |
All Works
Login with ORCID to disown or claim papers
Loading papers...